日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

International Consensus-Driven Recommendations for Patient-Reported Outcome Research Objectives in Early Phase Dose-Finding Oncology Trials: OPTIMISE-ROR

早期剂量探索性肿瘤试验中患者报告结局研究目标的国际共识驱动建议:OPTIMISE-ROR

Alger, Emily; Aiyegbusi, Olalekan Lee; Dueck, Amylou C; Minchom, Anna; Pe, Madeline; Peipert, John D; Snyder, Claire; Symeonides, Stefan N; Wilson, Roger; Basch, Ethan; Qiao, Yu; Bates, Susan E; Bulbeck, Helen; Dean, Lizzie; Di Maio, Massimo; Hansen, Aaron R; Kholmanskikh, Olga; Kobayashi, Ken; Landers, Dónal; Le Tourneau, Christophe; Lee, J Jack; Ma, Brigette B Y; Marshall, Lynley V; Patel, Sheetal; Petrie, Joan; Pond, Gregory R; Prior, Kieran; Rantell, Khadija R; Reeve, John F; Solovyeva, Olga; Wages, Nolan A; Weber, Harald A; Calvert, Melanie J; Yap, Christina

Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors

卡博替尼治疗晚期神经内分泌肿瘤的3期临床试验

Chan, Jennifer A; Geyer, Susan; Zemla, Tyler; Knopp, Michael V; Behr, Spencer; Pulsipher, Sydney; Ou, Fang-Shu; Dueck, Amylou C; Acoba, Jared; Shergill, Ardaman; Wolin, Edward M; Halfdanarson, Thorvardur R; Konda, Bhavana; Trikalinos, Nikolaos A; Tawfik, Bernard; Raj, Nitya; Shaheen, Shagufta; Vijayvergia, Namrata; Dasari, Arvind; Strosberg, Jonathan R; Kohn, Elise C; Kulke, Matthew H; O'Reilly, Eileen M; Meyerhardt, Jeffrey A

Quality of life outcomes in patients participating in the CALGB 30610 trial (CALGB 70702): Alliance

参与 CALGB 30610 试验(CALGB 70702)的患者的生活质量结果:联盟

Ganti, Apar K; Fruth, Briant; Rimner, Andreas; Waqar, Saiama; Mix, Michael D; Petty, W Jeffrey; Stinchcombe, Thomas E; Vokes, Everett E; Bogart, Jeffrey A; Dueck, Amylou C

Psychometric Properties and Interpretability of PRO-CTCAE(®) Average Composite Scores as a Summary Metric of Symptomatic Adverse Event Burden

PRO-CTCAE®平均综合评分作为症状性不良事件负担的总结指标的心理测量学特性和可解释性

Lee, Minji K; Mitchell, Sandra A; Basch, Ethan; Deal, Allison M; Langlais, Blake T; Thanarajasingam, Gita; Ginos, Brenda F; Rogak, Lauren; Mendoza, Tito R; Bennett, Antonia V; Noble, Brie N; Mazza, Gina L; Dueck, Amylou C

Prevalence of symptomatic toxicities for novel therapies in adult oncology trials: a scoping review

成人肿瘤临床试验中新型疗法症状性毒性的发生率:范围综述

King, Amanda L; Vasilj, Tamara; Cooper, Diane; Vera, Elizabeth; Berhanu, Sefanit; Johnson, Morgan; Locke, Ciara; Mciver, Bennett; Basch, Ethan; Cappelleri, Joseph C; Dueck, Amylou; Gilbert, Mark R; Jones, Lee; Li, Yuelin; Minasian, Lori M; Reeve, Bryce B; Armstrong, Terri S; Mendoza, Tito

Longitudinal graphics of patient-reported physical function in patients treated for hematologic malignancies

接受血液系统恶性肿瘤治疗的患者自述身体功能的纵向图表

Thanarajasingam, Gita; Bhatnagar, Vishal; Noble, Brie N; Chen, Ting-Yu; Fiero, Mallorie H; Hoffman, Ron; Jeffery, Molly; Mazza, Gina L; Mascarenhas, John; Mesa, Ruben; Murugappan, Meena; Ross, Joseph; Sidana, Surbhi; Warsame, Rahma; Kluetz, Paul G; Dueck, Amylou C

Identification of meaningful individual-level change thresholds for worsening on the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE®)

确定患者报告结局版不良事件通用术语标准 (PRO-CTCAE®) 中病情恶化的有意义的个体水平变化阈值

Lee, Minji K; Mitchell, Sandra A; Basch, Ethan; Mazza, Gina L; Langlais, Blake T; Thanarajasingam, Gita; Ginos, Brenda F; Rogak, Lauren; Meek, Eric A; Jansen, Jennifer; Deal, Allison M; Carr, Philip; Blinder, Victoria S; Jonsson, Mattias; Mody, Gita N; Mendoza, Tito R; Bennett, Antonia V; Schrag, Deborah; Dueck, Amylou C

Use of patient-reported outcomes version of the common terminology criteria for adverse events in oncology clinical trials

在肿瘤临床试验中使用患者报告结局版本的不良事件通用术语标准

Rogak, Lauren; Forschmiedt, Jamie K; Basch, Ethan; Mazza, Gina L; Lee, Minji K; Meek, Eric A; Ginos, Brenda; Langlais, Blake T; Noble, Brie N; Deal, Allison M; Yee, Claire; Thanarajasingam, Gita; Dueck, Amylou C

Symptom monitoring with electronic patient-reported outcomes during cancer treatment: final results of the PRO-TECT cluster-randomized trial

利用电子患者报告结局监测癌症治疗期间的症状:PRO-TECT 整群随机试验的最终结果

Basch, Ethan; Schrag, Deborah; Jansen, Jennifer; Henson, Sydney; Ginos, Brenda; Stover, Angela M; Carr, Philip; Spears, Patricia A; Jonsson, Mattias; Deal, Allison M; Bennett, Antonia V; Thanarajasingam, Gita; Rogak, Lauren; Reeve, Bryce B; Snyder, Claire; Bruner, Deborah; Cella, David; Kottschade, Lisa A; Perlmutter, Jane; Geoghegan, Cindy; Given, Barbara; Mazza, Gina L; Miller, Robert; Strasser, Jon F; Zylla, Dylan M; Weiss, Anna; Blinder, Victoria S; Wolf, Anna P; Dueck, Amylou C

Methods for implementing and reporting the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events to measure patient-reported adverse events in cancer clinical trials

用于在癌症临床试验中测量患者报告不良事件的患者报告结局版本(PRO)的实施和报告方法

Dueck, Amylou C; Thanarajasingam, Gita; Rogak, Lauren; Mazza, Gina L; Langlais, Blake T; Noble, Brie N; Ginos, Brenda F; Mead-Harvey, Carolyn; Yee, Claire I; Lee, Minji K; Deal, Allison M; Meek, Eric A; Basch, Ethan